首页> 外国专利> In the same year, the hospital prosecution body (CKD)

In the same year, the hospital prosecution body (CKD)

机译:同年,医院检察机关(CKD)

摘要

A potentially symptomatic chronic kidney disease (CKD), which is the last stage of kidney disease (ESRD), can be treated orally. A nontoxic lambda, alpha, V, theta, and alpha Alliance for the treatment of effective components of active ingredients. In a preferred composition, there is an integration of hydrated lanthanum carbonate or delta, and it is found to be lanthanum.Giving a coalition of lambda alpha_theta alpha_CDK can hinder progress, suggest it in the treatment of soft tissue calcification, and propose our The second is the treatment of the secondary PI.
机译:可以口服治疗潜在症状性慢性肾脏病(CKD),这是肾脏疾病(ESRD)的最后阶段。一种无毒的λ,α,V,θ和α联盟,用于治疗有效成分的有效成分。在一个优选的组合物中,存在水合碳酸镧或δ的整合物,并且发现是镧。给予lambda alpha_theta alpha_CDK的联盟可能会阻碍进展,建议在软组织钙化的治疗中提出,并提出我们的第二个建议。是对继发性PI的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号